TerrAscend (TSNDF) Cash & Current Investments (2021 - 2026)
TerrAscend's (TSNDF) quarterly Cash & Current Investments came in at $472000.0 in Q1 2026, down 98.44% year-on-year from $30.2 million in Q1 2025, and little changed on a QoQ basis from $472000.0 in Q4 2025.
TerrAscend (TSNDF) Cash & Current Investments (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Cash & Current Investments data on file, last reported at $472000.0 in Q1 2026.
- On a quarterly basis, Cash & Current Investments fell 98.44% year-over-year to $472000.0 in Q1 2026; TTM through Mar 2026 was $472000.0, a 98.44% decrease from a year earlier, with the FY2025 full-year figure at $472000.0, down 79.77% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $472000.0, roughly flat from $472000.0 in the prior quarter.
- Over the last five years, Cash & Current Investments for TSNDF reached as high as $92.5 million in Q1 2022 and fell as low as $472000.0 in Q4 2025.
- Historically, Cash & Current Investments has averaged $21.3 million across 5 years, with a median of $24.2 million in 2023.
- Across the five-year window, Cash & Current Investments soared 1025.13% in 2024 and slumped 98.44% in 2026, its largest moves.
- Year by year, Cash & Current Investments stood at $29.8 million in 2022, then slipped by 18.82% to $24.2 million in 2023, then plunged by 90.34% to $2.3 million in 2024, then sank by 79.77% to $472000.0 in 2025, then changed by 0.0% to $472000.0 in 2026.
- Per Business Quant data, the three most recent Cash & Current Investments figures were $472000.0 in Q1 2026, $472000.0 in Q4 2025, and $37.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | 1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 3.74 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 1.94 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 4.06 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 2.15 Bn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 1.80 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 1.32 Bn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 428.00 Mn |
| 10 | TerrAscend | 164.05 Mn | 163.57 Mn | 34.60 Mn | 472,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 472,000.00 |
| Dec 31, 2025 | 472,000.00 |
| Sep 30, 2025 | 37.51 Mn |
| Jun 30, 2025 | 27.66 Mn |
| Mar 31, 2025 | 30.23 Mn |
| Dec 31, 2024 | 2.33 Mn |
| Sep 30, 2024 | 28.39 Mn |
| Jun 30, 2024 | 4.85 Mn |
| Mar 31, 2024 | 5.08 Mn |
| Dec 31, 2023 | 24.15 Mn |
| Sep 30, 2023 | 2.52 Mn |
| Jun 30, 2023 | 30.85 Mn |
| Mar 31, 2023 | 2.63 Mn |
| Dec 31, 2022 | 29.75 Mn |
| Sep 30, 2022 | 37.84 Mn |
| Jun 30, 2022 | 4.68 Mn |
| Mar 31, 2022 | 92.53 Mn |
| Dec 31, 2021 | 79.64 Mn |